{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["4-Alkylaminoimidazo[1,2-a]pyridine", "Carbamates", "Synthesis", "\u03b1-Glucosidase"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "33047276", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "24"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "10", "Day": "12"}], "Language": ["eng"], "ELocationID": ["10.1007/s11030-020-10137-8"], "Journal": {"ISSN": "1573-501X", "JournalIssue": {"Volume": "25", "Issue": "4", "PubDate": {"Year": "2021", "Month": "Nov"}}, "Title": "Molecular diversity", "ISOAbbreviation": "Mol Divers"}, "ArticleTitle": "Synthesis of 4-alkylaminoimidazo[1,2-a]pyridines linked to carbamate moiety as potent \u03b1-glucosidase inhibitors.", "Pagination": {"StartPage": "2399", "EndPage": "2409", "MedlinePgn": "2399-2409"}, "Abstract": {"AbstractText": ["In this work, various imidazo[1,2-a]pyridines linked to carbamate moiety were designed, synthesized, and evaluated for their \u03b1-glucosidase inhibitory activity. Among synthesized compounds, 4-(3-(tert-Butylamino)imidazo[1,2-a]pyridin-2-yl)phenyl p-tolylcarbamate (6d) was the most potent compound (IC<sub>50</sub>\u2009=\u200975.6\u00a0\u00b5M) compared with acarbose as the reference drug (IC<sub>50</sub>\u2009=\u2009750.0\u00a0\u00b5M). Kinetic study of compound 6d indicated a competitive inhibition. Also, the molecular docking study suggested desired interactions with the active site residues. In particular, hydrogen bonds and electrostatic interactions constructed by compound 6d afforded well-oriented conformation in the 3A4A active site."], "CopyrightInformation": "\u00a9 2020. Springer Nature Switzerland AG."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Saeedi", "ForeName": "Mina", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Raeisi-Nafchi", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Sobhani", "ForeName": "Sepideh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, School of Pharmacy-International Campus, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Mirfazli", "ForeName": "Seyedeh Sara", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran, 1417614411, Iran."}], "LastName": "Zardkanlou", "ForeName": "Mahsa", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran, 1417614411, Iran."}], "LastName": "Mojtabavi", "ForeName": "Somayeh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran, 1417614411, Iran."}], "LastName": "Faramarzi", "ForeName": "Mohammad Ali", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran. akbarzad@tums.ac.ir."}, {"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. akbarzad@tums.ac.ir."}], "LastName": "Akbarzadeh", "ForeName": "Tahmineh", "Initials": "T"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mol Divers", "NlmUniqueID": "9516534", "ISSNLinking": "1381-1991"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Glycoside Hydrolase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Carbamates"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyridines"}, {"RegistryNumber": "EC 3.2.1.20", "NameOfSubstance": "alpha-Glucosidases"}, {"RegistryNumber": "0", "NameOfSubstance": "Imidazoles"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Glycoside Hydrolase Inhibitors"}, {"QualifierName": ["chemistry", "pharmacology", "chemical synthesis"], "DescriptorName": "Carbamates"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry", "chemical synthesis", "pharmacology"], "DescriptorName": "Pyridines"}, {"QualifierName": ["metabolism"], "DescriptorName": "alpha-Glucosidases"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemistry", "pharmacology", "chemical synthesis"], "DescriptorName": "Imidazoles"}, {"QualifierName": [], "DescriptorName": "Kinetics"}, {"QualifierName": [], "DescriptorName": "Catalytic Domain"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "van de Laar FA, Lucassen PL, Akkermans RP, van de Lisdonk EH, Rutten GE, van Weel C (2005) \u03b1-Glucosidase inhibitors for patients with type 2 diabetes: results from a cochrane systematic review and meta-analysis. Diabetes Care 28(1):154\u2013163. https://doi.org/10.2337/diacare.28.1.154", "ArticleIdList": ["10.2337/diacare.28.1.154", "15616251"]}, {"Citation": "van de Laar FA (2008) Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes. Vasc Health Risk Manag 4(6):1189\u20131195. https://doi.org/10.2147/vhrm.s3119", "ArticleIdList": ["10.2147/vhrm.s3119", "19337532", "2663450"]}, {"Citation": "Holman N, Young B, Gadsby R (2015) Current prevalence of Type 1 and Type 2 diabetes in adults and children in the UK. Diabet Med 32(9):1119\u20131120. https://doi.org/10.1111/dme.12791", "ArticleIdList": ["10.1111/dme.12791", "25962518"]}, {"Citation": "Liu Z, Ma S (2017) Recent advances in synthetic \u03b1-glucosidase inhibitors. ChemMedChem 12(11):819\u2013829. https://doi.org/10.1002/cmdc.201700216", "ArticleIdList": ["10.1002/cmdc.201700216", "28498640"]}, {"Citation": "Dhameja M, Gupta P (2019) Synthetic heterocyclic candidates as promising \u03b1-glucosidase inhibitors: an overview. Eur J Med Chem 176:343\u2013377", "ArticleIdList": ["10.1016/j.ejmech.2019.04.025"]}, {"Citation": "Saeedi M, Hadjiakhondi A, Nabavi SM, Manayi A (2017) Heterocyclic compounds: effective \u03b1-amylase and \u03b1-glucosidase inhibitors. Curr Top Med Chem 17(4):428\u2013440", "ArticleIdList": ["10.2174/1568026616666160824104655"]}, {"Citation": "Gruner SAW, Locardi E, Lohof E, Kessler H (2002) Carbohydrate-based mimetics in drug design: sugar amino acids and carbohydrate scaffolds. Chem Rev 102(2):491\u2013514. https://doi.org/10.1021/cr0004409", "ArticleIdList": ["10.1021/cr0004409", "11841252"]}, {"Citation": "Bagri P, Chester K, Khana W, Ahmad S (2017) Aspects of extraction and biological evaluation of naturally occurring sugar-mimicking sulfonium-ion and their synthetic analogues as potent \u03b1-glucosidase inhibitors from Salacia: a review. RSC Adv 7(54):28152\u201328185. https://doi.org/10.1039/C7RA02955A", "ArticleIdList": ["10.1039/C7RA02955A"]}, {"Citation": "Yin N, Zhang W, Feng F, Zhang Y, Kang W (2014) \u03b1-Glucosidase inhibitors isolated from medicinal plants. Food Sci Hum Wellness 3(3\u20134):136\u2013174. https://doi.org/10.1016/j.fshw.2014.11.003", "ArticleIdList": ["10.1016/j.fshw.2014.11.003"]}, {"Citation": "Liu H, Sim L, Rose DR, Pinto BM (2006) A new class of glucosidase inhibitor: analogues of the naturally occurring glucosidase inhibitor salacinol with different ring heteroatom substituents and acyclic chain extension. J Org Chem 71(8):3007\u20133013. https://doi.org/10.1021/jo052539r", "ArticleIdList": ["10.1021/jo052539r", "16599595"]}, {"Citation": "Hameed S, Kanwal Seraj F, Rafique R, Chigurupati S, Wadood A, Ur Rehman A, Venugopal V, Salar U, Taha M, Khan KM (2019) Synthesis of benzotriazoles derivatives and their dual potential as \u03b1-amylase and \u03b1-glucosidase inhibitors in vitro: structure\u2013activity relationship, molecular docking, and kinetic studies. Eur J Med Chem 18:111677. https://doi.org/10.1016/j.ejmech.2019.111677", "ArticleIdList": ["10.1016/j.ejmech.2019.111677"]}, {"Citation": "Xu XT, Deng XY, Chen J, Liang QM, Zhang K, Li DL, Wu PP, Zheng X, Zhou RP, Jiang ZY, Ma AJ, Chen WH, Wang SH (2019) Synthesis and biological evaluation of coumarin derivatives as \u03b1-glucosidase inhibitors. Eur J Med Chem 189:112013. https://doi.org/10.1016/j.ejmech.2019.112013", "ArticleIdList": ["10.1016/j.ejmech.2019.112013", "31972390"]}, {"Citation": "Saeedi M, Mohammadi-Khanaposhtani M, Asgari MS, Eghbalnejad N, Imanparast S, Faramarzi MA, Larijani B, Mahdavi M, Akbarzadeh T (2019) Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent \u03b1-glucosidase inhibitors. Bioorg Med Chem 27(23):115148. https://doi.org/10.1016/j.bmc.2019.115148", "ArticleIdList": ["10.1016/j.bmc.2019.115148", "31679980"]}, {"Citation": "Kaur R, Palta K, Kumar M (2019) Hybrids of isatin-pyrazole as potential \u03b1-glucosidase inhibitors: synthesis, biological evaluations and molecular docking studies. ChemistrySelect 4(45):13219\u201313227. https://doi.org/10.1002/slct.201903418", "ArticleIdList": ["10.1002/slct.201903418"]}, {"Citation": "Yousuf H, Shamim S, Khan KM, Chigurupati S, Kanwal Hameed S, Khan MN, Taha M, Arfeen M (2020) Dihydropyridines as potential \u03b1-amylase and \u03b1-glucosidase inhibitors: synthesis, in vitro and in silico studies. Bioorg Chem 96:103581. https://doi.org/10.1016/j.bioorg.2020.103581", "ArticleIdList": ["10.1016/j.bioorg.2020.103581", "31978686"]}, {"Citation": "Rafique R, Khan KM, Kanwal A, Chigurupati S, Wadood A, Ur Rehman A, Karunanidhi A, Hameed S, Taha M, al-Rashida M (2020) Synthesis of new indazole based dual inhibitors of \u03b1-glucosidase and \u03b1-amylase enzymes, their in vitro, in silico and kinetics studies. Bioorg Chem 94:103195. https://doi.org/10.1016/j.bioorg.2019.103195", "ArticleIdList": ["10.1016/j.bioorg.2019.103195", "31451297"]}, {"Citation": "Pogaku V, Gangarapu K, Basavoju S, Tatapudi KK, Katragadda SB (2019) Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent \u03b1-glucosidase inhibitors. Bioorg Chem 93:103307. https://doi.org/10.1016/j.bioorg.2019.103307", "ArticleIdList": ["10.1016/j.bioorg.2019.103307", "31585262"]}, {"Citation": "Taha M, Alshamrani FJ, Rahim F, Hayat S, Ullah H, Zaman K, Imran S (2019) Synthesis of novel triazinoindole-based thiourea hybrid: a study on \u03b1-glucosidase inhibitors and their molecular docking. Molecules 24(21):3819. https://doi.org/10.3390/molecules24213819", "ArticleIdList": ["10.3390/molecules24213819", "6864627"]}, {"Citation": "Taha M, Ismail NH, Imran S, Ainaa I, Selvaraj M, Syukri baharudin M, Ali M, Mohammed Khan K, Uddin N (2017) Synthesis of 2-phenyl-1H-imidazo[4,5-b]pyridine as type 2 diabetes inhibitors and molecular docking studies. Med Chem Res 26(5):916\u2013928. https://doi.org/10.1007/s00044-017-1806-0", "ArticleIdList": ["10.1007/s00044-017-1806-0"]}, {"Citation": "Deep A, Bhatia RK, Kaur R, Kumar S, Jain UK, Singh H, Batra S, Kaushik D, Deb PK (2017) Imidazo[1,2-a]pyridine scaffold as prospective therapeutic agents. Curr Top Med Chem 17(2):238\u2013250. https://doi.org/10.2174/1568026616666160530153233", "ArticleIdList": ["10.2174/1568026616666160530153233", "27237332"]}, {"Citation": "Goel R, Luxami V, Paul K (2016) Imidazo[1,2-a]pyridines: promising drug candidate for antitumor therapy. Curr Top Med Chem 16(30):3590\u20133616. https://doi.org/10.2174/1568026616666160414122644", "ArticleIdList": ["10.2174/1568026616666160414122644", "27086790"]}, {"Citation": "Gueiffier C, Gueiffier A (2007) Recent progress in the pharmacology of imidazol[1,2-a]pyridines. Mini Rev Med Chem 7(9):888\u2013899. https://doi.org/10.2174/138955707781662645", "ArticleIdList": ["10.2174/138955707781662645", "17897079"]}, {"Citation": "Yu Y, Han Y, Zhang F, Gao Z, Zhu T, Dong S, Ma M (2020) Design, synthesis, and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3K/mTOR dual inhibitors. J Med Chem 63(6):3028\u20133046. https://doi.org/10.1021/acs.jmedchem.9b01736", "ArticleIdList": ["10.1021/acs.jmedchem.9b01736", "32069401"]}, {"Citation": "Ramya PVS, Guntuku L, Angapelly S, Digwal CS, Lakshmi UJ, Sigalapalli DK, Babu BN, Naidu VGM, Kamalac A (2018) Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors. Eur J Med Chem 143:216\u2013231. https://doi.org/10.1016/j.ejmech.2017.11.010", "ArticleIdList": ["10.1016/j.ejmech.2017.11.010", "29174816"]}, {"Citation": "Chitti S, Singireddi SR, Reddy PSK, Trivedi P, Bobde Y, Kumar C, Rangan K, Ghosh B, Sekhar KVGC (2019) Design, synthesis and biological evaluation of 2-(3,4-dimethoxyphenyl)-6 (1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyridine analogues as antiproliferative agents. Bioorg Med Chem Lett 29(18):2551\u20132558. https://doi.org/10.1016/j.bmcl.2019.08.013", "ArticleIdList": ["10.1016/j.bmcl.2019.08.013", "31420269"]}, {"Citation": "Wang A, Lv K, Li L, Liu H, Tao Z, Wang B, Liu M, Ma C, Ma X, Han B, Wang A, Lu Y (2019) Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents. Eur J Med Chem 178:715\u2013725. https://doi.org/10.1016/j.ejmech.2019.06.038", "ArticleIdList": ["10.1016/j.ejmech.2019.06.038", "31229874"]}, {"Citation": "Zhou S, Chen G, Huang G (2018) Design, synthesis and biological evaluation of imidazo[1,2-a]pyridine analogues or derivatives as anti-helmintic drug. Chem Biol Drug Des 93(4):503\u2013510. https://doi.org/10.1111/cbdd.13441", "ArticleIdList": ["10.1111/cbdd.13441", "30427117"]}, {"Citation": "Prieto-Mart\u00ednez FD, L\u00f3pez-L\u00f3pez E, Ju\u00e1rez-Mercado KE, Medina-Franco JL (2019) Silico drug design: repurposing techniques and methodologies. In: In Roy K (ed) Computational drug design methods-current and future. Elsevier, Amsterdam, pp 19\u201344"}, {"Citation": "Popovi\u0107-Djordjevi\u0107 JB, Jevti\u0107 II, Grozdani\u0107 ND, \u0160egan SB, Zlatovi\u0107 MV, Ivanovi\u0107 MD, Stanojkovi\u0107 TP (2017) \u03b1-Glucosidase inhibitory activity and cytotoxic effects of some cyclic urea and carbamate derivatives. J Enzyme Inhib Med Chem 32(1):298\u2013303. https://doi.org/10.1080/14756366.2016.1250754", "ArticleIdList": ["10.1080/14756366.2016.1250754", "28100083", "6010093"]}, {"Citation": "Saeedi M, Mohammadi-Khanaposhtani M, Pourrabia P, Razzaghi N, Ghadimi R, Imanparast S, Faramarzi MA, Bandarian F, Esfahani EN, Safavi M, Rastegar H, Larijani B, Mahdavi M, Akbarzadeh T (2019) Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro \u03b1-glucosidase inhibition, kinetic, and docking study. Bioorg Chem 83:161\u2013196. https://doi.org/10.1016/j.bioorg.2018.10.023", "ArticleIdList": ["10.1016/j.bioorg.2018.10.023", "30366316"]}, {"Citation": "Abuelizz HA, Iwana NANI, Ahmad R, Anouar EH, Marzouk M, Al-Salahi R (2019) Synthesis, biological activity and molecular docking of new tricyclic series as \u03b1-glucosidase inhibitors. BMC Chem 13:52. https://doi.org/10.1186/s13065-019-0560-4", "ArticleIdList": ["10.1186/s13065-019-0560-4", "31384800", "6661812"]}, {"Citation": "Ali MY, Kim DH, Seong SH, Kim HR, Jung HA, Choi JS (2017) \u03b1-Glucosidase and protein tyrosine phosphatase 1B inhibitory activity of plastoquinones from marine brown alga Sargassum serratifolium. Mar Drugs 15:368. https://doi.org/10.3390/md15120368", "ArticleIdList": ["10.3390/md15120368", "5742828"]}, {"Citation": "Medina-Franco JL, Naveja JJ, L\u00f3pez-L\u00f3pez E (2019) Reaching for the bright StARs in chemical space. Drug Discov Today 24(11):2162\u20132169. https://doi.org/10.1016/j.drudis.2019.09.013", "ArticleIdList": ["10.1016/j.drudis.2019.09.013", "31557448"]}]}], "History": [{"Year": "2020", "Month": "6", "Day": "27"}, {"Year": "2020", "Month": "8", "Day": "25"}, {"Year": "2020", "Month": "10", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "13", "Hour": "5", "Minute": "40"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33047276", "10.1007/s11030-020-10137-8", "10.1007/s11030-020-10137-8"]}}]}